HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Successful treatment of refractory peripheral T-cell lymphoma by allogeneic peripheral blood stem cell transplantation].

Abstract
A 40-year-old man was admitted to our hospital suffering from abdominal pain. He revealed marked splenomegaly, lymphadenopathy and pancytopenia. Lymph node biopsy showed diffuse proliferation of medium to large atypical lymphoid cells. Immunohistochemically the cells were positive for T-cell markers. He was diagnosed as having peripheral T cell lymphoma (PTCL) with involvement of the spleen and bone marrow. Because of refractoriness to combination chemotherapies and splenic irradiation, we performed allogeneic peripheral blood stem cell transplantation from an HLA-identical sister. Conditioning was consisted of conventional doses of total body irradiation and cyclophosphamide, and GVHD prophylaxis was performed with cyclosporine and methotrexate. After the patient developed grade III graft-versus-host disease, his splenomegaly improved dramatically. Although the effectiveness of allogeneic hematopoietic cell transplantation in the treatment of malignant lymphoma is controversial, we should consider this as a second-line therapy to refractory subsets of PTCL.
AuthorsMotoaki Shiratsuchi, Satoru Suehiro, Youko Suehiro, Kenzaburo Tani, Koichi Ohshima, Satoshi Shiokawa, Junji Nishimura
Journal[Rinsho ketsueki] The Japanese journal of clinical hematology (Rinsho Ketsueki) Vol. 44 Issue 7 Pg. 456-61 (Jul 2003) ISSN: 0485-1439 [Print] Japan
PMID12931564 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Cyclosporine
Topics
  • Adult
  • Cyclosporine (administration & dosage)
  • Graft vs Host Disease (prevention & control)
  • Humans
  • Lymphoma, T-Cell, Peripheral (therapy)
  • Male
  • Peripheral Blood Stem Cell Transplantation
  • Transplantation Conditioning
  • Transplantation, Homologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: